We further extended our studies of BRCA-1/AhR cross-talk to human breast tumors, and found that compared to LUM-A, LUM-B, and HER-2-positive tumors, TNBC had higher AhR and BRCA-1 CpG methylation. The gene discussed is AHR; the disease is breast neoplasm.